The pattern no single source sees

Search

Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.

Company or person28

Cocrystal Pharma, Inc.

Company

6 records in the corpus

IGC Pharma, Inc.

Company

2 records in the corpus

aTYR PHARMA INC

Company

7 records in the corpus

Silo Pharma, Inc.

Company

6 records in the corpus

Helus Pharma Inc.

Company

12 records in the corpus

Traws Pharma, Inc.

Company

6 records in the corpus

Avalyn Pharma Inc.

Company

5 records in the corpus

BIOCRYST PHARMACEUTICALS INC

Company

9 records in the corpus

Lantern Pharma Inc.

Company

7 records in the corpus

Pharma-Bio Serv, Inc.

Company

1 records in the corpus

Nuvectis Pharma, Inc.

Company

2 records in the corpus

SpyGlass Pharma, Inc.

Company

2 records in the corpus

BridgeBio Pharma, Inc.

Company

12 records in the corpus

Liminatus Pharma, Inc.

Company

3 records in the corpus

REGENEREX PHARMA, INC.

Company

2 records in the corpus

COLLEGIUM PHARMACEUTICAL, INC

Company

8 records in the corpus

Cue Biopharma, Inc.

Company

11 records in the corpus

BetterLife Pharma Inc.

Company

1 records in the corpus

Corvus Pharmaceuticals, Inc.

Company

1 records in the corpus

CNS Pharmaceuticals, Inc.

Company

5 records in the corpus

CNBX Pharmaceuticals Inc.

Company

2 records in the corpus

Propanc Biopharma, Inc.

Company

2 records in the corpus

GT Biopharma, Inc.

Company

8 records in the corpus

Olema Pharmaceuticals, Inc.

Company

4 records in the corpus

ADIAL PHARMACEUTICALS, INC.

Company

16 records in the corpus

Raphael Pharmaceutical Inc.

Company

1 records in the corpus

CANNAPHARMARX, INC.

Company

1 records in the corpus

NUTRA PHARMA CORP

Company

4 records in the corpus

Primary record2

Cocrystal Pharma, Inc. filed SCHEDULE 13D/A

on August 13, 2026. 0000898860 N FROST PHILLIP MD ET AL OO N X1 2788106.00 0.00 2788106.00 0.00 2788106.00 N 13.9 IN (1) The amounts provided in Items 7, 9, and 11 include (i) 1,993,551 shares of Common Stock held by Fro

06 Nov 2026 · sec daily index

Inmune Bio, Inc. filed 8-K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 8, 2026, the Board of Directors (the Board ) of IN

14 Sep 2026 · sec daily index